Published in MMWR Recomm Rep on January 21, 2005
Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP) | NCT01214759
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17
Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis (2008) 5.85
Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr (2009) 5.48
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother (2010) 2.41
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis. Clin Infect Dis (2010) 2.07
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis (2014) 2.05
Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav (2011) 1.43
Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health (2010) 1.25
Community member perspectives from transgender women and men who have sex with men on pre-exposure prophylaxis as an HIV prevention strategy: implications for implementation. Implement Sci (2012) 1.24
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17
Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS One (2012) 1.14
Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention. Curr Opin HIV AIDS (2012) 1.13
A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men. AIDS Patient Care STDS (2012) 1.07
Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep (2015) 1.04
Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trial. AIDS Behav (2010) 0.99
HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas. J Acquir Immune Defic Syndr (2013) 0.98
A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIV. Clin Infect Dis (2011) 0.95
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061. J Acquir Immune Defic Syndr (2015) 0.94
Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis. AIDS Behav (2014) 0.93
Preparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxis. Am J Prev Med (2013) 0.93
Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013. AIDS Patient Care STDS (2015) 0.92
Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013. J Acquir Immune Defic Syndr (2015) 0.92
Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review. AIDS (2014) 0.92
Getting PrEPared for HIV Prevention Navigation: Young Black Gay Men Talk About HIV Prevention in the Biomedical Era. AIDS Patient Care STDS (2015) 0.90
Opportunities for HIV combination prevention to reduce racial and ethnic health disparities. Am Psychol (2013) 0.90
The human bite injury: a clinical audit and discussion regarding the management of this alcohol fuelled phenomenon. Emerg Med J (2007) 0.90
Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections. Hippokratia (2011) 0.90
Compliance in Rhode Island emergency departments with American Academy of Pediatrics recommendations for adolescent sexual assaults. Pediatrics (2008) 0.90
Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination. PLoS One (2010) 0.89
Current perspectives in HIV post-exposure prophylaxis. HIV AIDS (Auckl) (2014) 0.89
Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan. AIDS Educ Prev (2015) 0.89
Correlates of heterosexual anal intercourse among substance-using club-goers. Arch Sex Behav (2010) 0.88
Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men. AIDS Behav (2016) 0.88
Sexual assault injuries and increased risk of HIV transmission. Adv Emerg Nurs J (2012) 0.86
Interventions to prevent sexually transmitted infections, including HIV infection. Clin Infect Dis (2011) 0.86
Predictors of the initiation of HIV postexposure prophylaxis in Rhode Island emergency departments. AIDS Patient Care STDS (2008) 0.86
Effects of messaging about multiple biomedical and behavioral HIV prevention methods on intentions to use among US MSM: results of an experimental messaging study. AIDS Behav (2014) 0.86
Integrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early Treatment. Open Forum Infect Dis (2015) 0.85
Incorporating couples-based approaches into HIV prevention for gay and bisexual men: opportunities and challenges. Arch Sex Behav (2014) 0.85
Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States. Am J Law Med (2012) 0.85
The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention. Clin Infect Dis (2015) 0.84
Factors associated with sexual assault and time to presentation. Prev Med (2009) 0.84
The "Party Drug" Crystal Methamphetamine: Risk Factor for the Acquisition of HIV. Perm J (2008) 0.84
Risk behaviors and risk factors for HIV infection among participants in the Bangkok tenofovir study, an HIV pre-exposure prophylaxis trial among people who inject drugs. PLoS One (2014) 0.83
Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis. Curr Infect Dis Rep (2008) 0.83
Male circumcision and HIV status among Latino immigrant MSM in New York City. J LGBT Health Res (2007) 0.83
Non-occupational post-exposure prophylaxis for HIV: 10-year retrospective analysis in Seattle, Washington. PLoS One (2014) 0.82
Chemoprophylaxis for HIV prevention: new opportunities and new questions. J Acquir Immune Defic Syndr (2010) 0.82
Comparative study of the persistence of anti-HIV activity of deoxynucleoside HIV reverse transcriptase inhibitors after removal from culture. AIDS Res Ther (2009) 0.82
Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs. PLoS One (2012) 0.81
Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States. Infect Dis Rep (2011) 0.81
Uptake and repeat use of postexposure prophylaxis in a community-based clinic in Los Angeles, California. AIDS Res Hum Retroviruses (2014) 0.80
Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. PLoS One (2015) 0.80
Bite injuries to the hand: microbiology, virology and management. Open Orthop J (2014) 0.80
Post-exposure prophylaxis use and recurrent exposure to HIV among men who have sex with men who use crystal methamphetamine. Drug Alcohol Depend (2014) 0.80
Presentation of child sexual abuse cases to Queen Elizabeth Central Hospital following the establishment of an HIV post-exposure prophylaxis programme. Malawi Med J (2009) 0.80
Antiretroviral therapy for adults infected with HIV: Guidelines for health care professionals from the Quebec HIV care committee. Can J Infect Dis Med Microbiol (2011) 0.80
Update on the Epidemiology and Prevention of HIV/AIDS in the United States. Curr Epidemiol Rep (2015) 0.80
Maximizing the benefits of antiretroviral therapy for key affected populations. J Int AIDS Soc (2014) 0.79
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review. PLoS One (2015) 0.79
Emergency department evaluations of non-percutaneous blood or body fluid exposures during cardiopulmonary resuscitation. Prehosp Disaster Med (2007) 0.78
Antiretroviral-based HIV prevention strategies for women. Expert Rev Anti Infect Ther (2010) 0.78
The use of preexposure treatments for HIV prophylaxis. HIV AIDS (Auckl) (2012) 0.78
Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention. Pharm Pract (Granada) (2009) 0.78
Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center. PLoS One (2015) 0.78
Factors Associated With Forensic Nurses Offering HIV nPEP Status Post Sexual Assault. West J Nurs Res (2014) 0.78
A bite in the playroom: Managing human bites in child care settings. Paediatr Child Health (2008) 0.78
Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada. HIV Med (2016) 0.78
HIV-Negative Partnered Men's Willingness to Use Non-Occupational Post-Exposure Prophylaxis and Associated Factors in a U.S. Sample of HIV-Negative and HIV-Discordant Male Couples. LGBT Health (2015) 0.78
Pre-exposure prophylaxis of HIV: A right way to go or a long way to go? Artif Cells Nanomed Biotechnol (2014) 0.77
The essentials of HIV: a review for nurses. J Infus Nurs (2008) 0.77
Thirty years of the human immunodeficiency virus epidemic and beyond. Int J Oral Sci (2013) 0.77
Contingency management facilitates the use of postexposure prophylaxis among stimulant-using men who have sex with men. Open Forum Infect Dis (2015) 0.77
Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers). Infect Dis Clin North Am (2014) 0.76
Uptake to HIV post-exposure prophylaxis in Haiti: opportunities to align sexual violence, HIV PEP and mental health. Am J Reprod Immunol (2012) 0.76
HIV prevention for people who use substances: evidence-based strategies. J Food Drug Anal (2013) 0.76
Agent-based computational model of the prevalence of gonococcal infections after the implementation of HIV pre-exposure prophylaxis guidelines. Online J Public Health Inform (2015) 0.75
Preventing AIDS: the British experience. J Urban Health (2006) 0.75
Nonoccupational Postexposure Human Immunodeficiency Virus Prophylaxis: Acceptance Following Sexual Assault. Nurs Res (2015) 0.75
Improving Access to HIV and AIDS Information Resources for Patients, Caregivers, and Clinicians: Results from the SHINE Project. Online J Public Health Inform (2012) 0.75
Antiretroviral medication for preventing HIV infection in nonoccupational settings. CMAJ (2012) 0.75
Usability and Acceptability of a Mobile Comprehensive HIV Prevention App for Men Who Have Sex With Men: A Pilot Study. JMIR Mhealth Uhealth (2017) 0.75
High Levels of Concomitant Behavioral Health Disorders Among Patients Presenting for HIV Non-occupational Post-exposure Prophylaxis at a Boston Community Health Center Between 1997 and 2013. AIDS Behav (2016) 0.75
Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion. AIDS (2014) 0.75
Sexual assault: a report on human immunodeficiency virus postexposure prophylaxis. Obstet Gynecol Int (2010) 0.75
Attitudes toward Web application supporting pharmacist-clinician comanagement of postexposure prophylaxis patients. J Am Pharm Assoc (2003) (2013) 0.75
HIV: is a vaccine the answer? Hum Vaccin Immunother (2013) 0.75
Prevention literacy: community-based advocacy for access and ownership of the HIV prevention toolkit. J Int AIDS Soc (2016) 0.75
Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil. BMJ Open (2015) 0.75
Needle stick injuries in the community. Paediatr Child Health (2008) 0.75
Human Immunodeficiency Virus, Other Sexually Transmitted Infections, and Sexual and Reproductive Health in Lesbian, Gay, Bisexual, Transgender Youth. Pediatr Clin North Am (2016) 0.75
Factors associated with intention to take non-occupational HIV post-exposure prophylaxis among Thai men who have sex with men. J Virus Erad (2017) 0.75
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med (2012) 20.03
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med (2003) 8.05
Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS (2005) 5.43
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA (2008) 5.27
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis (2006) 5.24
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. AIDS (2007) 3.58
Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System. Public Health Rep (2007) 3.51
Increase in condom use and decline in HIV and sexually transmitted diseases among female sex workers in Abidjan, Côte d'Ivoire, 1991-1998. AIDS (2002) 2.97
Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA (2002) 2.81
Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med (2011) 2.72
Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS (2002) 2.64
Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol (2013) 2.59
Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet (2002) 2.50
Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health (2006) 2.42
Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep (2005) 2.35
Use of the community viral load as a population-based biomarker of HIV burden. AIDS (2012) 2.31
Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis (2004) 2.29
In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission. Antimicrob Agents Chemother (2004) 2.27
A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J Infect Dis (2005) 2.26
Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob Agents Chemother (2007) 2.22
Protection of human subjects. Code Fed Regul Public Welfare (1995) 2.15
In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr (2005) 1.99
Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatr Blood Cancer (2014) 1.98
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.97
p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A (2009) 1.89
A two-way messaging system to enhance antiretroviral adherence. J Am Med Inform Assoc (2003) 1.89
Superior temporal gyrus, language function, and autism. Dev Neuropsychol (2007) 1.89
Diffusion tensor imaging of white matter in the superior temporal gyrus and temporal stem in autism. Neurosci Lett (2007) 1.84
Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa. AIDS (2003) 1.80
National Tuberculosis Genotyping and Surveillance Network: design and methods. Emerg Infect Dis (2002) 1.78
Role of traditional birth attendants in preventing perinatal transmission of HIV. BMJ (2002) 1.72
Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis (2002) 1.72
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. MMWR Morb Mortal Wkly Rep (2015) 1.64
Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients. AIDS (2006) 1.59
Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol (2009) 1.58
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr (2013) 1.57
Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics (2007) 1.55
Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice. AIDS Res Hum Retroviruses (2012) 1.52
Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med (2002) 1.51
Phase I study of prolonged infusion Bryostatin-1 in patients with advanced malignancies. Cancer Biol Ther (2002) 1.50
Persistent inward currents in spinal motoneurons and their influence on human motoneuron firing patterns. Neuroscientist (2008) 1.48
Elevated HIV prevalence despite lower rates of sexual risk behaviors among black men in the District of Columbia who have sex with men. AIDS Patient Care STDS (2010) 1.44
Microfluidic sample preparation: cell lysis and nucleic acid purification. Integr Biol (Camb) (2009) 1.44
Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr (2005) 1.44
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother (2007) 1.42
Efficacy of a parent-based sexual-risk prevention program for African American preadolescents: a randomized controlled trial. Arch Pediatr Adolesc Med (2007) 1.39
Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr (2010) 1.39
Reduction in personal exposures to particulate matter and carbon monoxide as a result of the installation of a Patsari improved cook stove in Michoacan Mexico. Indoor Air (2008) 1.35
Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. AIDS (2009) 1.34
DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs. Emerg Infect Dis (2002) 1.32
Teams in organizations: from input-process-output models to IMOI models. Annu Rev Psychol (2005) 1.29
Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. AIDS (2007) 1.29
The impact of improved wood-burning stoves on fine particulate matter concentrations in rural Mexican homes. J Expo Sci Environ Epidemiol (2006) 1.25
Use of geosocial networking (GSN) mobile phone applications to find men for sex by men who have sex with men (MSM) in Washington, DC. AIDS Behav (2014) 1.25
Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother (2009) 1.21
Effectiveness of repeat single-dose nevirapine for prevention of mother-to-child transmission of HIV-1 in repeat pregnancies in Uganda. J Acquir Immune Defic Syndr (2007) 1.20
Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities. Am J Public Health (2004) 1.20
Medication data collection and coding in a home-based survey of older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.20
High and persistent HIV seroincidence in men who have sex with men across 47 U.S. cities. PLoS One (2012) 1.19
Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes (2008) 1.17
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. MMWR Surveill Summ (2016) 1.16
Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am J Physiol Cell Physiol (2008) 1.15
An inexpensive light-scattering particle monitor: field validation. J Environ Monit (2007) 1.12
Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy. Case Rep Med (2010) 1.11
Influenza vaccination coverage among pregnant women--National 2009 H1N1 Flu Survey (NHFS). Am J Obstet Gynecol (2011) 1.10
A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies. AIDS (2002) 1.10
Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008). AIDS Patient Care STDS (2012) 1.09
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. Eur J Pharmacol (2008) 1.08
CD4(+) cell count, viral load, and drug resistance patterns among heterosexual breakthrough HIV infections in a study of oral preexposure prophylaxis. AIDS (2014) 1.08
MsrA knockout mouse exhibits abnormal behavior and brain dopamine levels. Free Radic Biol Med (2008) 1.08
Treatment of latent tuberculosis infection in contacts of new tuberculosis cases in the United States. South Med J (2002) 1.07
Influenza vaccination coverage among pregnant women--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.06
Temporal association between expanded HIV testing and improvements in population-based HIV/AIDS clinical outcomes, District of Columbia. AIDS Care (2013) 1.06
POSaM: a fast, flexible, open-source, inkjet oligonucleotide synthesizer and microarrayer. Genome Biol (2004) 1.06
Movement-related receptive fields of spinal motoneurones with active dendrites. J Physiol (2008) 1.05
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS (2002) 1.05
Toward eliminating health disparities in HIV/AIDS: the importance of the minority investigator in addressing scientific gaps in Black and Latino communities. J Natl Med Assoc (2006) 1.03
Implementing a novel citywide rapid HIV testing campaign in Washington, D.C.: findings and lessons learned. Public Health Rep (2012) 1.03
Temporal lobe, autism, and macrocephaly. AJNR Am J Neuroradiol (2003) 1.02
High prevalence of substance use among heterosexuals living in communities with high rates of AIDS and poverty in Washington, DC. Drug Alcohol Depend (2011) 1.02
Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. J Urban Health (2013) 1.02
A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol (2002) 1.01
Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care (2002) 1.01
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention. AIDS Res Hum Retroviruses (2013) 0.98
Pancreatic cyst aspiration analysis for cystic neoplasms: mucin or carcinoembryonic antigen--which is better? Surgery (2010) 0.98
Radiation induces diffusible feeder cell factor(s) that cooperate with ROCK inhibitor to conditionally reprogram and immortalize epithelial cells. Am J Pathol (2013) 0.97
Lateral diffusion coefficients in membranes measured by resonance energy transfer and a new algorithm for diffusion in two dimensions. Biophys J (2002) 0.97
The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel. Vaccine (2012) 0.96
Quantification of the spatial distribution of rectally applied surrogates for microbicide and semen in colon with SPECT and magnetic resonance imaging. Br J Clin Pharmacol (2012) 0.95
Veterinary virologists share avian flu data. Science (2006) 0.95
Preventing HIV infection in women. J Acquir Immune Defic Syndr (2013) 0.95
Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis. J Org Chem (2006) 0.95
Retracted Specific armadillo repeat sequences facilitate β-catenin nuclear transport in live cells via direct binding to nucleoporins Nup62, Nup153, and RanBP2/Nup358. J Biol Chem (2011) 0.94
HIV quality performance measures in a large integrated health care system. AIDS Patient Care STDS (2011) 0.94
Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med (2013) 0.93